Cytoreduction status and platinum sensitivity in women with recurrent ovarian cancer
Publication
, Conference
De Oca, MKM; Reid, H; Davidson, B
Published in: GYNECOLOGIC ONCOLOGY
2021
Duke Scholars
Published In
GYNECOLOGIC ONCOLOGY
EISSN
1095-6859
ISSN
0090-8258
Publication Date
2021
Volume
162
Start / End Page
S122 / S123
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
De Oca, M. K. M., Reid, H., & Davidson, B. (2021). Cytoreduction status and platinum sensitivity in women with recurrent ovarian cancer. In GYNECOLOGIC ONCOLOGY (Vol. 162, pp. S122–S123).
De Oca, Mary Katherine Montes, Hadley Reid, and Brittany Davidson. “Cytoreduction status and platinum sensitivity in women with recurrent ovarian cancer.” In GYNECOLOGIC ONCOLOGY, 162:S122–23, 2021.
De Oca MKM, Reid H, Davidson B. Cytoreduction status and platinum sensitivity in women with recurrent ovarian cancer. In: GYNECOLOGIC ONCOLOGY. 2021. p. S122–3.
De Oca, Mary Katherine Montes, et al. “Cytoreduction status and platinum sensitivity in women with recurrent ovarian cancer.” GYNECOLOGIC ONCOLOGY, vol. 162, 2021, pp. S122–23.
De Oca MKM, Reid H, Davidson B. Cytoreduction status and platinum sensitivity in women with recurrent ovarian cancer. GYNECOLOGIC ONCOLOGY. 2021. p. S122–S123.
Published In
GYNECOLOGIC ONCOLOGY
EISSN
1095-6859
ISSN
0090-8258
Publication Date
2021
Volume
162
Start / End Page
S122 / S123
Related Subject Headings
- Oncology & Carcinogenesis
- 3215 Reproductive medicine
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1114 Paediatrics and Reproductive Medicine
- 1112 Oncology and Carcinogenesis